Searched for
INJECTIVE PRICE
Vedanta listing: How billionaire Anil Agarwal's 'Fantastic 5' unlocked Rs 63,500 crore value with mega demergerVedanta’s long-awaited demerger culminated with the listing of four newly spun-off businesses, triggering a sharp market re-rating and unlo...- Explained: Why RBI’s FCNR(B) and ECB swap window could be a game changer for banksRBI’s FCNR(B) and ECB swap windows aim to boost liquidity, stabilise the rupee and ease funding costs for banks. Attractive returns for NRI...
- European shares rally as Middle East peace hopes drag oil prices lowerEuropean shares surged on Friday, driven by renewed hopes for a Middle East diplomatic breakthrough that lowered oil prices. The pan-Europe...
- Countering maritime contestation: India, France set to deepen undersea defence capabilitiesIndia and France are set to strengthen defense cooperation. Prime Minister Narendra Modi's visit to France will focus on accelerating key m...
- BlackRock says oil, FX risks loom over India's bond inflow pushIndian debt is piquing the interest of foreign investors thanks to new government initiatives. Nonetheless, investment giant BlackRock rema...
- UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
- Cancer drug prices raised 50% as NPPA acts on shortage concernsIndia's drug pricing authority has approved a 50% price hike for essential anti-cancer drugs carboplatin and cisplatin. This decision follo...
- US jobless aid filings rise to 229,000 last week, remain historically low despite Iran war headwindsAmerica's jobless claims saw a slight increase last week, yet remain historically low. This comes despite economic challenges linked to the...
- SpaceX’s IPO success may rub off on AmbaniInvestor interest in major tech offerings remains strong. Mukesh Ambani's Jio Platforms is preparing for a significant IPO in India. Howeve...
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
- Asian stocks fall, oil gains as US strikes IranUS forces launched fresh strikes on Iran, escalating geopolitical risks and sending oil prices up over 2%. This development, coupled with a...
- Government may lift price cap on cancer drugs making them costlier by up to 50%India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy age...
- Customers will feast as Zepto to pour fuel into quick commerce fireZepto’s proposed Rs 9,500 cr ($1 billion) IPO could significantly intensify competition in India’s already crowded quick commerce market. T...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
- FIFA 2026: Brokerages bet on sector winners as soccer World Cup set to kick offThe 2026 FIFA World Cup will bring billions to host nations. Analysts expect a surge in spending on hotels, airlines, and retail. Beer sale...
- Dry ice’s use, devised in India, pioneered culinary advancementsGases are vital for modern life. From cooling vaccines to preserving food, their impact is immense. An Indian doctor's early innovation wit...
- Small packs make big gains as budgets shrink and costs riseWith inflation on the rise, Indian shoppers are favoring compact product packaging. This shift not only reflects changing consumer habits b...
- FIFA WC 2026 set to be a free kick for tourism, retail and clothing industryAnalysts said U.S. hotel operators Marriott, Hilton and Hyatt as well as online travel platforms Airbnb, Booking Holdings and Expedia are p...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- Bio Medica Laboratories shares to debut today. Here's what GMP suggests ahead of listingBio Medica Laboratories' shares are set to list on the NSE SME platform amidst weak grey market sentiment, with the IPO currently trading a...
Load More
